Health Canada Authorizes Pfizer-BioNTech COVID-19 Vaccine Targeting the Omicron XBB.1.5 Subvariant
Health Canada has authorized the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for individuals six months of age and older. Health Canada received Pfizer-BioNTech’s submission on June… Read More



